Look for:

Our offer for

ABBVIE INC.


ISIN:
US00287Y1091
WKN:
00287Y109

2022/09/23 22:03:23
Price
143.06 USD
Difference 0.03% (0.05)

General attributes

ISINUS00287Y1091
SymbolABBV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)257,086 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)141.60 USD (500)
Ask (Ask size)143.50 USD (100)
Open142.07 USD
High143.4199 USD
Low140.9534 USD
Close (prev. day)143.01 USD
VWAP142.361483 USD
Volume (pcs)5,751,553
Trading volume819,104,698.76
Number of trades68,471
Last size680,060

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Annual report: ABBVIE INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/09/23 22:03:23
Price
143.06 USD
Difference 0.03% (0.05)

General attributes

ISINUS00287Y1091
SymbolABBV
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)257,086 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)141.60 USD (500)
Ask (Ask size)143.50 USD (100)
Open142.07 USD
High143.4199 USD
Low140.9534 USD
Close (prev. day)143.01 USD
VWAP142.361483 USD
Volume (pcs)5,751,553
Trading volume819,104,698.76
Number of trades68,471
Last size680,060

Performance and Risk

6M1Y3Y
Perf (%)-9.70%+33.25%+96.16%
Perf (abs.)-15.36+35.70+70.13
Beta0.310.320.63
Volatility24.3021.2426.80
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)142.16 USD (5,312,796)
Ø price 30 days | Ø volume 30 days (pcs.)140.05 USD (4,910,537)
Ø price 100 days | Ø volume 100 days (pcs.)145.83 USD (5,806,240)
Ø price 250 days | Ø volume 250 days (pcs.)139.37 USD (6,695,170)
YTD High | date175.91 USD (2022/04/08)
YTD Low | date128.26 USD (2022/01/24)
52 Weeks High | date175.91 USD (2022/04/08)
52 Weeks Low | date106.44 USD (2021/09/24)

All listings for ABBVIE INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/09/2317:35146.14 EUR0.1121
Vienna Stock Exchange2022/09/2317:32146.46 EUR0.002
Tradegate2022/09/2322:26147.66 EUR0.5184
Stuttgart2022/09/2321:12146.22 EUR0.005
NYSE2022/09/2322:03143.06 USD819.1068,471
Munich2022/09/2319:18146.02 EUR0.002
London Stock Exchange European Trade Reporting2022/09/2317:30142.24 USD0.005
Frankfurt2022/09/2318:23145.64 EUR0.084
Duesseldorf2022/09/2321:00145.94 EUR0.0012
Berlin2022/09/2321:45147.34 EUR0.0018

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=138490&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABBVIE INC.
- -
1 North Waukegan Road - 60064-6400 North Chicago
Telefon: 1-847-932-7900
Fax: -
E-mail: -

PDF Downloads

Annual report: ABBVIE INC.PDF Download

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Members of Management Board

Robert AlpernMember of Board of Directors
Brett HartMember of Board of Directors
Edward RappMember of Board of Directors
Frederick WaddellMember of Board of Directors
Glenn TiltonMember of Board of Directors
Melody MeyerMember of Board of Directors
Rebecca RobertsMember of Board of Directors
Robert MichaelMember of Board of Directors
Roxanne AustinMember of Board of Directors
Thomas FreymanMember of Board of Directors
William BurnsideMember of Board of Directors
Richard A. GonzalezChairman of Managing Board
Azita Saleki-GerhardtMember of Executive Committee
Carrie StromMember of Executive Committee
Henry O. GosebruchMember of Executive Committee
Jeffrey R. StewartMember of Executive Committee
Laura J. SchumacherMember of Executive Committee
Perry C. SiatisMember of Executive Committee
Rae L. LivingstonMember of Executive Committee
Robert A. MichaelMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.